CLBT Jul 2024 12.500 put
- GlobeNewswire
Cellebrite Announces First-Quarter 2024 Results
ARR of $331.8 million, up 27% year-over-year; Q1 2024 revenue of $89.6 million, up 26% year-over-year primarily due to 29% growth in subscription revenue; Q1 2024 adjusted EBITDA of $17.6 million, 19.7% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 23, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 202
- GlobeNewswire
Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company plans to participate in the following investor conferences in May and June: Date:May 26, 2024Conference:Oppenheimer 25thAnnual Israeli ConferencePresentation Time:11:10 ILFormat:Fireside ChatEvent URL:https://investors.cellebrite.com/events/event-details/oppenheimer-2
- Simply Wall St.
An Intrinsic Calculation For Cellebrite DI Ltd. (NASDAQ:CLBT) Suggests It's 33% Undervalued
Key Insights The projected fair value for Cellebrite DI is US$16.82 based on 2 Stage Free Cash Flow to Equity...
